Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


MacroGenics reported $-38009000 in Net Income for its fiscal quarter ending in March of 2023.

Net Income Change
AbbVie ABBV:US USD 239M 2.23B
Amgen AMGN:US USD 2.84B 1.23B
AstraZeneca AZN:LN USD 1.8B 902M
Biogen BIIB:US USD 387.9M 162.5M
Bristol-Myers Squibb BMY:US USD 2.26B 240M
Daiichi Sankyo 4568:JP JPY 22.49B 5.9B
Eli Lilly LLY:US USD 1.34B 592.8M
Genmab GEN:DC DKK 226M 358M
Geron GERN:US USD -38122000 4.51M
Gilead Sciences GILD:US USD 1.01B 630M
Immunogen IMGN:US USD -41014000 17.99M
J&J JNJ:US USD -68000000 3.59B
Karyopharm Therapeutics KPTI:US USD -34126000 4.38M
MacroGenics MGNX:US USD -38009000 50.81M
Merck & Co MRK:US USD 2.82B 196M
Mirati Therapeutics MRTX:US USD -184586000 17.89M
Pfizer PFE:US USD 5.54B 548M
Puma Biotechnology PBYI:US USD 1.4M 7.01M
Regeneron Pharmaceuticals REGN:US USD 817.8M 379.3M
Roche Holding ROG:VX 3.89B 4.64B
Seattle Genetics SGEN:US USD -174737000 26.57M
Xencor XNCR:US USD -60763000 48.72M